Main Article Content
Background: Plasma interference is a problem for coagulation analyzers using a photo-optical detection method. Sysmex®
CS-2100i is a fully-automated coagulation analyzer which has been developed to reduce this problem.
Objective: To evaluate the influence of interferences on prothrombin time (PT), activated partial thromboplastin time (APTT),
and fibrinogen analyzed by Sysmex® CS-2100i. The performance of this analyzer was also assessed in this study.
Methods: Pooled plasma samples spiked with interfering substances including hemoglobin, bilirubin and lipid were used in
the interference study. Real patients’ samples with these interferences were also tested. Control materials and pooled samples
were used for precision, comparison, and carryover studies.
Results: The PT, APTT, and fibrinogen could be analyzed in both plasma samples with interference added and real abnormal
patients’ plasma samples. The deviation of PT, APTT, and fibrinogen levels was not obvious, except for an upward trend
of fibrinogen level with increased hemoglobin. The highest % CV of PT, APTT, and fibrinogen were 1.24, 3.18, and 4.31,
respectively for within-run and 2.32, 2.11, and 6.06, respectively for between-run precision analysis. The correlation coefficients
of PT, APTT, and fibrinogen between Sysmex® CS-2100i and Sysmex® CA-1500 were 0.99, 0.99, and 0.98 with intra-class
correlation coefficients of 0.99, 0.99, and 0.98 respectively. No significant carryover of specimen was observed.
Conclusion: Sysmex® CS-2100i could analyze both samples with artificial interfering substance added and real abnormal patients’
samples. This machine also had an acceptable performance by our evaluation.
All articles published in the Siriraj Medical Journal (SMJ) are protected by copyright. No material in this journal may be reproduced on any platform including electronic or in print or transmitted by any means, in whole or in part, without the prior written permission of the Editor of the SMJ. Written permission must also be obtained before any part of the SMJ is stored in any retrieval system of any nature.
A practical guide for pathologists. 1st ed. New York: Springer Science+Business Media; 2007. p. 41-56.
2. Salvagno GL, Lippi G, Bassi A, Poli G, Guidi GC. Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory.
J Eval Clin Pract. 2008 Apr;14(2):351-3.
3. Mukaide K. The multi-wavelength detection feature of the new automated blood coagulation analyzer - CS-2000i/CS-2100i. J Anal Bio-Sci. 2009;
4. ISO 15189:2007 (E) Standard. Medical laboratories - particular requirements for quality and competence. ISO, Geneva.
5. Serum index solution [package insert]. Indianapolis. In: Roche Diagnostics; 2007.
6. Gardiner C, Kitchen S, Dauer RJ, Kottke-Marchant K, Adcock DM. Recommendations for Evaluation of Coagulation Analyzers. Lab Hematol.
7. Bennett ST. Validation of coagulation assays, instruments and reagents. In: Bennett ST, Lehman CM, Rodgers GM, eds. Laboratory hemostasis:
A practical guide for pathologists. 1st ed. New York: Springer Science+Business Media; 2007. p. 57-84.
8. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar;33(1):159-74.
9. Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that
sample? Blood Coagul Fibrinolysis. 2006 Oct;17(7):513-9.
10. Laga AC, Cheves TA, Sweeney JD. The effect of specimen hemolysis on coagulation test results. Am J Clin Pathol. 2006 Nov;126(5):748-55.
11. US Department of Health and Human Services: Clinical laboratory improvements amendments of 1988. Final rule. Laboratory requirements.
Federal Register, 1992.